References
- Saito T, Moataz R, Dulon D. Cisplatin blocks depolarization-induced calcium entry in isolated cochlear hair cells. Hear Res 1991; 56: 143–7
- Yamamoto T, Kakehata S, Saito T, Saito H, Akaike N. Cisplatin blocks voltage-dependent calcium current in dissociated outer hair cells of guinea pig cochlea. Brain Res 1994; 648: 296–8
- Kimitsuki T, Nakagawa T, Hisashi K, Komune S, Komiyama S. Cisplatin blocks mechano-electric transducer current in chick cochlear hair cells. Hear Res 1993; 71: 64–8
- McAlpine D, Jonestone BM. The ototoxic mechanism of cisplatin. Hear Res 1990; 47: 191–204
- Nakagawa T, Kakehata S, Akaike N, Komune S, Takasaka T, Uemura T. Effects of Ca2 + antagonists and aminoglycoside antibiotics on Ca2+ current in isolated outer hair cells of guinea pig cochlea. Brain Res 1992; 580: 345–7
- Daley-Yates P, McBrien D CH. Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumor activity of cisplatin. Biochem Pharmacol 1984; 33: 3063–70
- Huang MY, Schacht J. Formation of a cytotoxic metabolite from gentamicin by liver. Biochem Pharmacol 1990; 40: Rll–4
- Garetz S L, Rhee D J, Schacht J. Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro. Hear Res 1994; 77: 75–80
- Zenner H P, Keiner S, Zimmermann U. Specific glu-tathione-SH inhibition of toxic effects of metabolized gentamicin on isolated guinea pig hair cells. Eur Arch Otorhinolaryngol 1994; 251: 84–90
- Maron D M, Ames BN. Revised methods for salmonella mutagenicity test. Handbook of mutagenicity test procedures., D J Kilbey, M Legator, W Nichols, C Ramel. Elsevier Science Publishers, Amsterdam 1984; 93–140
- Jones K H, Senft JS. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate propidium iodide. J Histochem Cytochem 1985; 33: 77–9
- Olefirowicz T M, Ewing AG. Capillary electrophoresis with indirect amperometric detection. J Chromato-graph 1990; 499: 713–719
- Nakai Y, Konishi K, Chang K C, et al. Ototoxicity of the anticancer drug cisplatin. An experimental study. Acta Otolaryngol (Stockh) 1982; 93: 227–32
- Laurell G, Bagger-Sjoback D. Degeneration of the organ of Corti following intravenous administration of cisplatin. Acta Otolaryngol (Stockh) 1991; 111: 891–8
- Schweitzer VG. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope 1993; 1–52, Suppl 59
- Saito T, Aran J-M. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL 1994; 56: 315–20
- Ohtani I, Anzai T, Aikawa T, Okamura H. Toxicity of carboplatin vs. cisplatin. Otolaryngology (Kyoto) 1989; 49–55, Suppl 32
- Safirstein R, Miller P, Guttenplan JB. Uptake and metabolism of cisplatin by rat kidney. Kidney Int 1984; 25: 753–8
- Tran Ba, Huy P, Bernard P, Schacht J. Kinetics of gentamicin uptake and release in the rat: Comparison of inner ear tissue and fluids with other organs. J Clin Invest 1986; 77: 1492–500
- Borch RF. The platinum anti-tumor drugs. Metabolism and actions of anticancer drugs., G Powis, RA Prough. Taylor & Francis, London 1987; 163–93
- Saito T, Aran J-M. X-ray microanalysis and ion microscopy of guinea pig cochlea and kidney after cis-platin treatment. ORL 1994; 56: 310–4
- Litterst CL. Cisplatinum: a review, with special references to cellular and molecular interactions. Agents Actions 1984; 15: 520–4
- Hanneman J, Baumann K. Nephrotoxicity of cisplatin, carboplatin, and transplatin. Arch Toxicol 1990; 64: 393–400